Seres Therapeutics

MCRBNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$40.380 M

$4.02 -1.23%

Close of 22 Sept 2026

Revenue

$789.0K

#3500 by revenue

Earnings

$5.70M

#2165 by earnings

Shares outstanding

9,941,261

Latest filing cover page

P/E ratio

7.1

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#364Karyopharm TherapeuticsKPTI$41.3M
#365Incannex HealthcareIXHL$40.6M
#366Seres TherapeuticsMCRB$40.4M
#367NanoviricidesNNVC$39.1M
#368CervoMedCRVO$38.3M

What if Seres Therapeutics were worth as much as…

Open the what-if tool →

Gold $30.2T

$3,009,918

Per share 748,736× higher

Bitcoin $1.74T

$173,389.05

Per share 43,132× higher

Nvidia $5.52T

$549,117.69

Per share 136,596× higher

Or at a round number

$50.0M $100.0M $200.0M $500.0M

Where these numbers come from

Share counts and financials for Seres Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.